Teva to close New Jersey plant it calls underutilized, cutting 61 jobs
Start here
Teva has signaled the closure of a manufacturing plant in New Jersey that the company describes as underutilized. The move comes with 61 job cuts, which Teva announced in advance of the shutdown. The disclosure was brief: the company has not said when the plant will actually close, which roles will be eliminated, or what severance affected workers will receive. For a generics giant that has spent years consolidating its manufacturing footprint, the closure fits a broader pattern of cost-driven site rationalization, but the practical details of the wind-down are still undisclosed.
Written by a model from the reports · updated 2 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- news.google.comTeva telegraphs 61 job cuts amid plans to close 'underutilized' New Jersey plant - Fierce Pharma
Teva plans to close a New Jersey plant described as "underutilized" and has given notice of 61 job cuts. Fierce Pharma's report did not disclose implementation details such as the plant closure timeline, the categories of jobs being cut, or severance arrangements.
Heat trend for this story
Heat now 7·Peak in the comparable set 10 (Oct 28 05:00)·Change over 24h in the comparable set –·Participants now 1
Participants counted above, heat below. The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's reading; the left and right arrow keys work too.